Rise of the Quality and Compliance Committee to Mitigate Risk

Add to iCal Calendar 0

Date/Time
Date(s) - 28 Sep 2022
7:45 AM - 9:30 AM

Location


Rise of the Quality and Compliance Committee to Mitigate Risk

Hosted by the NACD Pacific Southwest Chapter

September 28, 2022 – Online

  • 7:45 – 9:00 AM PT (Program)
  • 9:00 – 9:30 AM PT (Optional Networking)
  • Cost:  $30 for NACD Members and $50 for Guests

REGISTER

Please join our expert panel as they discuss the following questions and more:

  • What allowed management and directors to raise billions of dollars for an unproven technology?
  • What regulatory safeguards were missed, endangering patients?
  • How could directors have known that highly technical board-level explanations of the clinical and business models were fraudulent?
  • What is the role of the Scientific Advisory Board and Quality and Compliance Committee?
  • Why are Quality and Compliance Committees nearly ubiquitous for healthcare, pharma, and device companies today when they were largely absent only 10 years ago?
  • If your company does not have a Quality and Compliance Committee, what is the next best “work around” to avoid a “Theranos Meltdown”?

Speakers

  • Terry McInnis, Director – Calviri
  • Jean Pierre Millon, Director – CVS Health
  • Jacque Sokolov, Chairman and CEO – SSB Solutions